Delineating the impact of COVID-19 on antimicrobial resistance: An Indian perspective.


Journal

The Science of the total environment
ISSN: 1879-1026
Titre abrégé: Sci Total Environ
Pays: Netherlands
ID NLM: 0330500

Informations de publication

Date de publication:
20 Apr 2022
Historique:
received: 30 08 2021
revised: 24 10 2021
accepted: 11 11 2021
pubmed: 20 11 2021
medline: 11 3 2022
entrez: 19 11 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has shattered millions of lives globally and continues to be a challenge to public health due to the emergence of variants of concern. Fear of secondary infections following COVID-19 has led to an escalation in antimicrobial use during the pandemic, while some antimicrobials have been repurposed as treatments for SARS-CoV-2, further driving antimicrobial resistance. India is one of the largest producers and consumers of antimicrobials globally, hence the task of curbing antimicrobial resistance is a huge challenge. Practices like empirical antimicrobial prescription and repurposing of drugs in clinical settings, self-medication and excessive use of antimicrobial hygiene products may have negatively impacted the prevalence of antimicrobial resistance in India. However, the expanded production of antimicrobials and disinfectants during the pandemic in response to increased demand may have had an even greater impact on the threat of antimicrobial resistance through major impacts on the environment. The review provides an outline of the impact COVID-19 can have on antimicrobial resistance in clinical settings and the possible outcomes on the environment. This review calls for the upgrading of existing antimicrobial policies and emphasizes the need for research studies to understand the impact of the pandemic on antimicrobial resistance in India.

Identifiants

pubmed: 34798093
pii: S0048-9697(21)06778-4
doi: 10.1016/j.scitotenv.2021.151702
pmc: PMC8592853
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Anti-Infective Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

151702

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Clin Microbiol Infect. 2021 Apr;27(4):520-531
pubmed: 33418017
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Indian J Med Res. 2019 Feb;149(2):164-179
pubmed: 31219080
Lancet. 2021 Jun 26;397(10293):2461-2462
pubmed: 34139198
Sci Total Environ. 2006 Mar 1;356(1-3):143-53
pubmed: 15936058
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2674-9
pubmed: 10716995
J Antimicrob Chemother. 2020 Nov 1;75(11):3411-3412
pubmed: 32785691
Environ Sci Pollut Res Int. 2018 Oct;25(29):29518-29528
pubmed: 30136185
Biol Lett. 2016 Aug;12(8):
pubmed: 27531155
J Fungi (Basel). 2020 Jun 24;6(2):
pubmed: 32599813
Environ Pollut. 2013 Mar;174:305-15
pubmed: 23302545
Indian J Med Microbiol. 2021 Jul;39(3):380-383
pubmed: 34052046
Front Microbiol. 2020 May 13;11:1020
pubmed: 32574253
Trends Ecol Evol. 2011 Jun;26(6):278-84
pubmed: 21458879
Nat Med. 2019 Sep;25(9):1370-1376
pubmed: 31406349
Lancet Respir Med. 2020 Jun;8(6):e48-e49
pubmed: 32445626
PLoS Negl Trop Dis. 2011 Mar 29;5(3):e998
pubmed: 21468315
Nat Rev Microbiol. 2020 Aug;18(8):409-410
pubmed: 32488173
Ann Intensive Care. 2020 Jun 1;10(1):71
pubmed: 32488446
Emerg Infect Dis. 2011 Oct;17(10):1791-8
pubmed: 22000347
Plasmid. 2018 Sep;99:99-111
pubmed: 30243983
Bioresour Technol. 2012 Jun;113:253-8
pubmed: 22330590
Bull World Health Organ. 2020 Jul 1;98(7):442-442A
pubmed: 32742026
Chemosphere. 2015 Sep;135:138-45
pubmed: 25950407
Clin Infect Dis. 2019 Aug 1;69(4):563-570
pubmed: 30407501
Antimicrob Resist Infect Control. 2020 Sep 22;9(1):154
pubmed: 32962759
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470
pubmed: 29581252
J Infect Dev Ctries. 2021 Apr 30;15(4):501-505
pubmed: 33956649
Mycopathologia. 2020 Aug;185(4):599-606
pubmed: 32737747
Future Microbiol. 2019 Jul;14:829-831
pubmed: 31368794
J Antimicrob Chemother. 2007 Jun;59(6):1197-9
pubmed: 17475629
Proc Natl Acad Sci U S A. 2021 Feb 9;118(6):
pubmed: 33472859
Int J Infect Dis. 2016 Sep;50:75-82
pubmed: 27522002
Emerg Infect Dis. 2008 Jan;14(1):70-2
pubmed: 18258081
Lancet. 2021 May 8;397(10286):1683
pubmed: 33965073
Lancet. 2020 Mar 28;395(10229):1063-1077
pubmed: 32145185
Mycoses. 2020 Jun;63(6):528-534
pubmed: 32339350
Anal Chem. 2004 Aug 15;76(16):4756-64
pubmed: 15307787
J Antimicrob Chemother. 2005 Jul;56(1):20-51
pubmed: 15914491
Emerg Infect Dis. 2020 Nov;26(11):2694-2696
pubmed: 32852265
Sci Total Environ. 2015 Dec 1;536:946-954
pubmed: 26094800
Environ Sci Technol. 2014 Jul 15;48(14):7825-32
pubmed: 24988042
Indian J Ophthalmol. 2021 Feb;69(2):244-252
pubmed: 33463566
Clin Microbiol Infect. 2021 Mar;27(3):451-457
pubmed: 33223114
Lancet Glob Health. 2020 Dec;8(12):e1453-e1454
pubmed: 33188730
Eur Respir J. 1996 Jul;9(7):1523-30
pubmed: 8836669
J Fungi (Basel). 2020 Sep 06;6(3):
pubmed: 32899996
EMBO Mol Med. 2020 Jul 7;12(7):e12560
pubmed: 32453917
Water Res. 2003 Apr;37(8):1685-90
pubmed: 12697213
Environ Sci Technol. 2002 Jun 1;36(11):2322-9
pubmed: 12075785
Emerg Infect Dis. 2020 Jul;26(7):1636-1637
pubmed: 32343223
Int J Antimicrob Agents. 2020 Dec;56(6):106179
pubmed: 32987104
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146
pubmed: 34192610
J Infect Public Health. 2021 May;14(5):570-576
pubmed: 33848886
Nature. 2021 May;593(7859):321-322
pubmed: 33976409
Curr Infect Dis Rep. 2007 May;9(3):186-92
pubmed: 17430699
Environ Health Perspect. 2008 Nov;116(11):1563-7
pubmed: 19057712
Mycopathologia. 2020 Aug;185(4):607-611
pubmed: 32737746
Lancet Infect Dis. 2020 Oct;20(10):1118
pubmed: 32311322
J Travel Med. 2019 Dec 23;26(8):
pubmed: 31115466
Microorganisms. 2021 Mar 04;9(3):
pubmed: 33806386
J Infect Public Health. 2021 May;14(5):555-560
pubmed: 33848884
J Antimicrob Chemother. 2020 Nov 1;75(11):3386-3390
pubmed: 32766706
Ups J Med Sci. 2014 May;119(2):113-6
pubmed: 24697355
Nature. 1999 Sep 16;401(6750):233-4
pubmed: 10499578
Clin Microbiol Infect. 2021 Jan;27(1):83-88
pubmed: 32745596
ISME J. 2017 Mar;11(3):651-662
pubmed: 27959344
Mil Med Res. 2020 Feb 6;7(1):4
pubmed: 32029004
Sci Rep. 2017 Jan 25;7:41230
pubmed: 28120869
Trop Med Health. 2021 Jun 23;49(1):51
pubmed: 34162445
Int J Infect Dis. 2021 Apr;105:256-260
pubmed: 33508478
Vet Microbiol. 2012 Jul 6;158(1-2):147-52
pubmed: 22397929
Indian J Med Microbiol. 2021 Apr;39(2):147-153
pubmed: 33966856
Clin Infect Dis. 2021 Mar 1;72(5):e120-e127
pubmed: 33515460
Curr Opin Crit Care. 2020 Oct;26(5):433-441
pubmed: 32739970
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468
pubmed: 32358954
J Hosp Infect. 2007 Jun;65 Suppl 2:60-72
pubmed: 17540245
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399
pubmed: 32603803
Water Res. 2010 Jan;44(2):658-68
pubmed: 20106500
Sci Total Environ. 2009 Apr 1;407(8):2711-23
pubmed: 19138787
J Hazard Mater. 2021 Aug 15;416:126125
pubmed: 34492919
FEMS Microbiol Rev. 2018 Jul 1;42(4):489-499
pubmed: 29945240
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5649-54
pubmed: 25792457
Sci Total Environ. 2019 Jan 10;647:1626-1639
pubmed: 30180366
iScience. 2021 Apr 23;24(4):102304
pubmed: 33748695
Infect Drug Resist. 2021 May 24;14:1893-1903
pubmed: 34079300
J Infect Dis. 2003 Apr 15;187(8):1314-8
pubmed: 12696012
Lancet Microbe. 2021 Jun;2(6):e238
pubmed: 34100006
J Hazard Mater. 2007 Sep 30;148(3):751-5
pubmed: 17706342
Environ Sci Technol. 2005 May 15;39(10):3421-9
pubmed: 15952345
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Sci Total Environ. 1998 Dec 11;224(1-3):167-76
pubmed: 9926432
Indian J Med Res. 2011 Sep;134:281-94
pubmed: 21985810
J Wildl Dis. 2012 Jan;48(1):56-67
pubmed: 22247374
Curr Opin Infect Dis. 2004 Jun;17(3):185-91
pubmed: 15166819
Pathogens. 2020 Aug 05;9(8):
pubmed: 32764228
Curr Opin Biotechnol. 2008 Jun;19(3):260-5
pubmed: 18534838
Environ Sci Technol. 2003 Aug 1;37(15):286A-294A
pubmed: 12966963
Chem Res Toxicol. 2014 Oct 20;27(10):1821-8
pubmed: 25211553
Trends Microbiol. 2006 Apr;14(4):176-82
pubmed: 16537105
Front Microbiol. 2014 Dec 02;5:648
pubmed: 25520706
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
Clin Infect Dis. 2021 May 4;72(9):1657-1659
pubmed: 32544232
J Infect Dis. 2008 Oct 1;198(7):962-70
pubmed: 18710327
Appl Environ Microbiol. 1998 Feb;64(2):626-32
pubmed: 9464401
Lancet Infect Dis. 2016 Nov;16(11):1261-1268
pubmed: 27568359

Auteurs

P S Seethalakshmi (PS)

Department of Microbiology, Pondicherry University, Puducherry 605014, India. Electronic address: vimisha.ps@gmail.com.

Oliver J Charity (OJ)

NIHR Health Protection Research Unit in Healthcare associated infection and AMR, Department of Infectious Disease, Imperial College London, UK. Electronic address: o.charity@imperial.ac.uk.

Theodoros Giakoumis (T)

Centre for Environmental Policy, Imperial College London, London, UK. Electronic address: theodoros.giakoumis13@imperial.ac.uk.

George Seghal Kiran (GS)

Department of Food Science and Technology, Pondicherry University, Puducherry 605014, India.

Shiranee Sriskandan (S)

NIHR Health Protection Research Unit in Healthcare associated infection and AMR, Department of Infectious Disease, Imperial College London, UK; MRC Centre for Molecular Bacteriology & Infection, Imperial College London, UK. Electronic address: s.sriskandan@imperial.ac.uk.

Nikolaos Voulvoulis (N)

Centre for Environmental Policy, Imperial College London, London, UK. Electronic address: n.voulvoulis@imperial.ac.uk.

Joseph Selvin (J)

Department of Microbiology, Pondicherry University, Puducherry 605014, India. Electronic address: jselvin.mib@pondiuni.edu.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH